ELIGIBILITY ASSESSMENT FOR INTRAVENOUS THROMBOLYTIC THERAPY IN ACUTE ISCHEMIC STROKE PATIENTS; EVALUATING BARRIERS FOR IMPLEMENTATION

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

AYROMLOU HORMOZ; SOLEIMANPOUR HASSAN; FARHOUDI MEHDI; TAHERAGHDAM ALIAKBAR; SADEGHI HOKMABADI ELYAR; RAJAEI GHAFOURI ROUZBEH; NAJAFI NASHALI MEHDI; SHARIFIPOUR EHSAN; MOSTAFAEI SOMAYEH; ALTAFI DAVAR

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Red Crescent Medical Journal Year:2014 | Volume:16 | Issue:5 Page(s): 1-4

Download Full-Text

View:

291

Download:

131

Cites:

Information Journal Paper

Title

ELIGIBILITY ASSESSMENT FOR INTRAVENOUS THROMBOLYTIC THERAPY IN ACUTE ISCHEMIC STROKE PATIENTS; EVALUATING BARRIERS FOR IMPLEMENTATION

Author(s)

Keywords

STROKE

THROMBOLYTIC THERAPY

DEVELOPING COUNTRY

ELIGIBILITY DETERMINATION

Abstract

Background: Intravenous thrombolysis is an approved treatment method for patients with acute ischemic STROKE (AIS) and is recommended by multiple guidelines. However, it seems that it is less frequently used in the developing countries compared to the developed countries.Objectives: The purpose of this study was to estimate the percentage of patients with AIS, eligible for intravenous THROMBOLYTIC THERAPY, at the main referral center in Northwest Iran and to determine the main barriers for implementation of this method.Patients and Methods: Over one year, 647 patients who were admitted to the emergency department and met the Cincinnati STROKE Scale were enrolled into the study. The center to which patients were admitted, is a tertiary university hospital that has the required infrastructure for THROMBOLYTIC THERAPY in AIS. Factors recorded were neurological examinations and time between onset of symptoms and hospital arrival, hospital arrival and performance of brain computed tomography (CT) scanning, and hospital arrival to complete the investigations. Patients eligible for intravenous THROMBOLYTIC THERAPY were identified according to the American Heart Association (AHA) guidelines.Results: Mean time interval between hospital arrival and completion of brain CT scanning was 91 minutes (range: 20–378 minutes) and mean time from hospital arrival to completion of investigations was 150 minutes (range: 30–540 minutes). A total of 159 (31.3%) patients arrived at hospital within 3 hours of the onset of symptoms (early enough for intravenous THROMBOLYTIC THERAPY). However, 81.7% (130.159) of these patients missed THROMBOLYTIC THERAPY due to delayed performance of brain CT scanning and laboratory tests and 38.3% (61.159) had contraindications. The remaining 16 patients (10% of those who arrived within 3 hours and 3.1% of all cases) were eligible for THROMBOLYTIC THERAPY.Conclusions: The major barriers for THROMBOLYTIC THERAPY for patients with AIS in this setting were delays in the provision of in-hospital services, like initial patient assessment, CT scans or laboratory studies. These results were in contrast with previous reports.

Cites

No record.

References

No record.

Cite

APA: Copy

AYROMLOU, HORMOZ, SOLEIMANPOUR, HASSAN, FARHOUDI, MEHDI, TAHERAGHDAM, ALIAKBAR, SADEGHI HOKMABADI, ELYAR, RAJAEI GHAFOURI, ROUZBEH, NAJAFI NASHALI, MEHDI, SHARIFIPOUR, EHSAN, MOSTAFAEI, SOMAYEH, & ALTAFI, DAVAR. (2014). ELIGIBILITY ASSESSMENT FOR INTRAVENOUS THROMBOLYTIC THERAPY IN ACUTE ISCHEMIC STROKE PATIENTS; EVALUATING BARRIERS FOR IMPLEMENTATION. IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ), 16(5), 1-4. SID. https://sid.ir/paper/292600/en

Vancouver: Copy

AYROMLOU HORMOZ, SOLEIMANPOUR HASSAN, FARHOUDI MEHDI, TAHERAGHDAM ALIAKBAR, SADEGHI HOKMABADI ELYAR, RAJAEI GHAFOURI ROUZBEH, NAJAFI NASHALI MEHDI, SHARIFIPOUR EHSAN, MOSTAFAEI SOMAYEH, ALTAFI DAVAR. ELIGIBILITY ASSESSMENT FOR INTRAVENOUS THROMBOLYTIC THERAPY IN ACUTE ISCHEMIC STROKE PATIENTS; EVALUATING BARRIERS FOR IMPLEMENTATION. IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ)[Internet]. 2014;16(5):1-4. Available from: https://sid.ir/paper/292600/en

IEEE: Copy

HORMOZ AYROMLOU, HASSAN SOLEIMANPOUR, MEHDI FARHOUDI, ALIAKBAR TAHERAGHDAM, ELYAR SADEGHI HOKMABADI, ROUZBEH RAJAEI GHAFOURI, MEHDI NAJAFI NASHALI, EHSAN SHARIFIPOUR, SOMAYEH MOSTAFAEI, and DAVAR ALTAFI, “ELIGIBILITY ASSESSMENT FOR INTRAVENOUS THROMBOLYTIC THERAPY IN ACUTE ISCHEMIC STROKE PATIENTS; EVALUATING BARRIERS FOR IMPLEMENTATION,” IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ), vol. 16, no. 5, pp. 1–4, 2014, [Online]. Available: https://sid.ir/paper/292600/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops